These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18056831)

  • 21. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.
    Carminati GG; Deriaz N; Bertschy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):312-5. PubMed ID: 16307837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
    Mintzer JE; Brawman-Mintzer O
    J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of behavioral problems in intellectually disabled adult patients with epilepsy.
    Kerr M; Gil-Nagel A; Glynn M; Mula M; Thompson R; Zuberi SM
    Epilepsia; 2013 Mar; 54 Suppl 1():34-40. PubMed ID: 23458464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggression and self-injurious behaviors in persons with autism--the TEACCH (Treatment and Education of Autistic and related Communications Handicapped Children) approach.
    Cox RD; Schopler E
    Acta Paedopsychiatr; 1993; 56(2):85-90. PubMed ID: 8135116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of self-injurious behavior and other maladaptive behaviors among individuals with severe and profound intellectual disability.
    Matson JL; Cooper C; Malone CJ; Moskow SL
    Res Dev Disabil; 2008; 29(2):141-8. PubMed ID: 17350800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers for aggression in inpatient treatment facilities for adults with mild to borderline intellectual disability.
    Tenneij NH; Didden R; Stolker JJ; Koot HM
    Res Dev Disabil; 2009; 30(6):1248-57. PubMed ID: 19464143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
    Unwin GL; Deb S
    Am J Ment Retard; 2008 Jan; 113(1):19-31. PubMed ID: 18173296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of risperidone in children with epilepsy.
    Holzhausen SP; Guerreiro MM; Baccin CE; Montenegro MA
    Epilepsy Behav; 2007 May; 10(3):412-6. PubMed ID: 17382594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporary increases in problem behavior and sleep disruption following decreases in medication: a descriptive analysis of conditional rates.
    Rapp JT; Swanson G; Dornbusch K
    Behav Modif; 2007 Nov; 31(6):825-46. PubMed ID: 17932238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats.
    Haller J; Horváth Z; Bakos N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):27-31. PubMed ID: 16893596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance.
    Lott RS; Kerrick JM; Cohen SA
    Psychopharmacol Bull; 1996; 32(4):721-9. PubMed ID: 8993095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disability.
    Matson JL; Rivet TT
    J Intellect Dev Disabil; 2008 Dec; 33(4):323-9. PubMed ID: 19039692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study.
    Janowsky DS; Kraus JE; Barnhill J; Elamir B; Davis JM
    J Clin Psychopharmacol; 2003 Oct; 23(5):500-4. PubMed ID: 14520128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self injurious behavior in autism: clinical aspects and treatment with risperidone.
    Canitano R
    J Neural Transm (Vienna); 2006 Mar; 113(3):425-31. PubMed ID: 16075185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.